MAP2K7 and central nervous system cancer: It has been shown that in gliomas OCT4 expression is maintained by the transcription factors FOXO1 and FOXO3 and suppressed by PI3K/Akt/mTOR, and its level is significantly enhanced when PI3K is inhibited simultaneously with mTOR or MEK [37].